| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Anatara Lifesciences Limited (AU: ANR)
ANR Technical Analysis
5
| As on 11th Mar 2025 ANR STOCK Price closed @ 0.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.03 & Strong Sell for SHORT-TERM with Stoploss of 0.03 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ANRSTOCK Price
| Open | 0.01 | Change | Price | % |
| High | 0.01 | 1 Day | 0.00 | 0.00 |
| Low | 0.01 | 1 Week | -0.03 | -75.00 |
| Close | 0.01 | 1 Month | -0.04 | -80.00 |
| Volume | 12552317 | 1 Year | -0.02 | -66.67 |
| 52 Week High 0.07 | 52 Week Low 0.02 | ||||
AU Australia Most Active Stocks
| NIC | 0.60 | -21.05% |
| SYA | 0.02 | 0.00% |
| IMU | 0.03 | -25.00% |
| VEN | 0.00 | % |
| PLS | 1.76 | -3.83% |
| BTR | 0.02 | 0.00% |
| TLS | 4.09 | -0.49% |
| MGR | 2.08 | -0.95% |
| OSL | 0.00 | % |
| SIG | 2.80 | -3.11% |
AU Australia Top Gainers Stocks
AU Australia Top Losers Stocks
| ANR Daily Charts |
ANR Intraday Charts |
Whats New @ Bazaartrend |
ANR Free Analysis |
|
|
ANR Important Levels Intraday
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
ANR Forecast March 2025
| 4th UP Forecast | 0.03 |
| 3rd UP Forecast | 0.02 |
| 2nd UP Forecast | 0.02 |
| 1st UP Forecast | 0.02 |
| 1st DOWN Forecast | 0 |
| 2nd DOWN Forecast | 0 |
| 3rd DOWN Forecast | -0 |
| 4th DOWN Forecast | -0.01 |
ANR Weekly Forecast
| 4th UP Forecast | 0.03 |
| 3rd UP Forecast | 0.02 |
| 2nd UP Forecast | 0.02 |
| 1st UP Forecast | 0.02 |
| 1st DOWN Forecast | 0.00 |
| 2nd DOWN Forecast | 0.00 |
| 3rd DOWN Forecast | 0.00 |
| 4th DOWN Forecast | -0.01 |
ANR Forecast2025
| 4th UP Forecast | 0.13 |
| 3rd UP Forecast | 0.09 |
| 2nd UP Forecast | 0.07 |
| 1st UP Forecast | 0.04 |
| 1st DOWN Forecast | -0.02 |
| 2nd DOWN Forecast | -0.05 |
| 3rd DOWN Forecast | -0.07 |
| 4th DOWN Forecast | -0.11 |
Anatara Lifesciences Limited ( AU Australia Symbol : ANR )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ANR Business Profile
Anatara Lifesciences Limited engages in the research and development of evidence based solutions for gastrointestinal diseases in animals and humans in Australia. It offers Gastrointestinal ReProgramming (GaRP), a proprietary formulation that combines bromelain with other evidence-based ingredients to address the primary underlying factors associated with human gastrointestinal conditions, such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD); and 3FDC for the treatment of anxiety, stress, or depression. The company also provides Detach for the treatment of diarrhea disease in piglets. In addition, it is developing bromelain-based formulations for piglets and poultry. Anatara Lifesciences Limited was incorporated in 2010 and is based in Carlton, Australia. Address: 62 Lygon Street, Carlton, VIC, Australia, 3053
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service